Aptevo Therapeutics announces special shareholder meeting

• Aptevo will hold a virtual special stockholder meeting on Sept. 22, 2026.
• Votes are set on an amended and restated certificate of incorporation, including the Series A Junior Participating Preferred Stock designation.
• Shareholder authorization sought for issuance tied to Inducement Warrants and Common Warrants, enabling potential exercise for common stock.
• Approval also sought for the Fifth Amended and Restated 2018 Stock Incentive Plan, adding 180,000 shares for equity awards.
• Stockholders will also vote on a proposal to adjourn the meeting if more time is needed to secure votes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-376763), on August 31, 2026, and is solely responsible for the information contained therein.